|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Aisling Capital Management LP
✚
|
|
|---|---|
| CRD # | 269994 |
| SEC # | 801-106625 |
| CIK # | 0001571076, 0001766721 |
| AUM | $446.2 M (2025-03-28) |
| Employees | 12 (67% Investors, 0% Brokers) |
| Phone | 212-651-6380 |
| Address | 489 Fifth Avenue New York, NY 10017 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Bridgebio Pharma Inc | 262.0 | ||
| Verona Pharma PLC | 58.2 | ||
| Syndax Pharmaceuticals Inc | 12.3 | ||
| Monte Rosa Therapeutics Inc | 6.6 | ||
| Bicara Therapeutics Inc | 5.3 | ||
| Panacea Acquisition Corp | 5.0 | ||
| Biomea Fusion Inc | 3.7 | ||
| Compass Pathways PLC | 3.4 | ||
| Graybug Vision Inc | 0.8 | ||
| Aclaris Therapeutics Inc | 0.6 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Aisling Capital V LP | [2020-03-30] | 144.2 | 177.1 |
| PE | Aisling Capital IV LP | [2015-08-31] | 143.1 | 269.0 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 446.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 446.2 |
| By Discretionary | ||
| Discretionary | 2 | 446.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 446.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 446.2 | |
| Total | 2 | 446.2 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Steven Elms | 39 | ||
| Andrew Schiff | 16 | ||
| Aisling Capital Partners V LP | 1 | ||
| Aisling Capital Partners IV LLC | 1 | ||
| Aisling Capital Partners IV LP | 1 | ||
| Aisling Capital Partners V LLC | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001571076] | |
| 13F-HR | [0001766721] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
HGC Advisor LLC
✚
|
0.4 | |
|
Cimarron Healthcare Capital LLC
✚
|
UT | 0.4 |
|
Iron Path Capital LP
✚
|
VA | 0.4 |
|
Newvest Management LP
✚
|
0.4 | |
|
GIP Investment Adviser LLC
✚
|
FL | 0.4 |
|
C Cubed Capital Partners LLC
✚
|
FL | 0.4 |
|
Sage Advisors LLC
✚
|
NY | 0.4 |
|
Greenridge Equity Partners LLC
✚
|
TX | 0.4 |
|
Benford Capital Partners Management LP
✚
|
IL | 0.4 |
|
Stonecourt Capital LP
✚
|
NY | 0.4 |